{"id":10329,"date":"2023-02-03T15:05:36","date_gmt":"2023-02-03T14:05:36","guid":{"rendered":"http:\/\/bigman.to\/?post_type=product&#038;p=10329"},"modified":"2026-08-13T22:02:02","modified_gmt":"2026-08-13T20:02:02","slug":"pharma-lab-t3t4-50-tabs-30-120-mcg-tab-tab","status":"publish","type":"product","link":"https:\/\/bigman.to\/lv\/produkts\/pharma-lab-t3t4-50-tabs-30-120-mcg-tab-tab\/","title":{"rendered":"Pharma Lab T3+T4 50 tabs (30 + 120 mcg\/tab)"},"content":{"rendered":"<h2>Liotiron\u012bns - Cytomel<\/h2><p>Vairogdziedzera hormoni ir \u013coti svar\u012bgi m\u016bsu organisma funkcion\u0113\u0161anai, un to vienk\u0101r\u0161\u0101s molekul\u0101r\u0101s strukt\u016bras d\u0113\u013c tos var sintez\u0113t sint\u0113tiski. Divi galvenie vairogdziedzera hormonu veidi ir T4, kas paz\u012bstams k\u0101 levotiroks\u012bns, un T3, kas paz\u012bstams k\u0101 liotiron\u012bns; abi \u0161ie hormoni tiek ra\u017eoti un uzglab\u0101ti vairogdziedzer\u012b.<\/p><p>Sint\u0113tiskos vairogdziedzera hormonus var ieg\u016bt no dz\u012bvnieku izcelsmes avotiem (piem\u0113ram, liellopu vai aitu) vai piln\u012bb\u0101 izgatavot laboratorij\u0101s. Amerikas Savienotaj\u0101s Valst\u012bs ir stingri noteikumi, kas reglament\u0113 joda saturu vairogdziedzera prepar\u0101tos.<\/p><p>Cytomel (liotiron\u012bna n\u0101trija s\u0101ls) ir pieejams k\u0101 tablet, padarot to par pla\u0161i lietotu \u0161\u012b sp\u0113c\u012bg\u0101 hormona s\u0101li. T3 ir iev\u0113rojami efekt\u012bv\u0101ks nek\u0101 T4.<\/p><h3>Farmakolo\u0123ija<\/h3><p>Prec\u012bzi vairogdziedzera hormonu darb\u012bbas meh\u0101nismi nav piln\u012bb\u0101 izprasti, ta\u010du to funkcijas izraisa daudzas bio\u0137\u012bmiskas izmai\u0146as \u0161\u016bn\u0101s. Vairogdziedzera hormoniem ir iz\u0161\u0137iro\u0161a noz\u012bme ener\u0123ijas veido\u0161an\u0101, og\u013chidr\u0101tu, lip\u012bdu un olbaltumvielu metabolisma uzlabo\u0161an\u0101 un sk\u0101bek\u013ca pat\u0113ri\u0146a palielin\u0101\u0161an\u0101, t\u0101d\u0113j\u0101di paaugstinot baz\u0101lo metabolisma \u0101trumu. Tie ietekm\u0113 gandr\u012bz visus org\u0101nus, tostarp smadzenes, uzsverot \u0161o hormonu noz\u012bmi, jo \u012bpa\u0161i cilv\u0113kiem ar to tr\u016bkumu.<\/p><h3>Doz\u0113\u0161ana<\/h3><p>Vairogdziedzera hormoni no ku\u0146\u0123a-zarnu trakta \u0101tri uzs\u016bcas asin\u012bs, un to iedarb\u012bba parasti izpau\u017eas da\u017eu stundu laik\u0101, bet maksim\u0101la aktivit\u0101te var ilgt vair\u0101kas dienas. \u0160ie hormoni organism\u0101 var palikt akt\u012bvi vair\u0101kas dienas, jo tie saist\u0101s ar album\u012bnu asin\u012bs, kas pasarg\u0101 tos no no\u0101rd\u012b\u0161an\u0101s akn\u0101s.<\/p><ul>\n<li>Aizvietojo\u0161a terapija hipotireozei<\/li>\n<li>P\u0113c \u0137irur\u0123iskas vairogdziedzera iz\u0146em\u0161anas<\/li>\n<li>Goiteru un vairogdziedzera mezglu \u0101rst\u0113\u0161ana<\/li>\n<li>Diagnostiska izmanto\u0161ana supresijas testos, lai at\u0161\u0137irtu hipertireozi no vairogdziedzera autonomijas<\/li>\n<li>Tiem, kam ir aler\u0123ija pret c\u016bku vai liellopu vairogdziedzera vairogdziedzeri, var izv\u0113l\u0113ties Cytomel tablets.<\/li>\n<\/ul><h3>\u0136erme\u0146a veidot\u0101ji un svara zudums<\/h3><p>Jau gadiem ilgi sportisti - gan amatieri, gan profesion\u0101\u013ci - ir \u013caunpr\u0101t\u012bgi lietoju\u0161i vairogdziedzera hormonus, lai nomestu m\u0101rci\u0146as. Daudzi ir izmantoju\u0161i \u0161o efektu, lai zaud\u0113tu svaru un uzlabotu sportisko sniegumu, jo tas veicina tauku un og\u013chidr\u0101tu sadedzin\u0101\u0161anu. Cytomel parasti izmanto da\u017e\u0101dos sporta veidos. Sportisti bie\u017ei lieto hormonu iek\u0161\u0137\u012bgi 4-6 ned\u0113\u013cas, p\u0101rtraucot to ned\u0113\u013cu pirms sacens\u012bb\u0101m. Lai gan tas ir efekt\u012bvs tauku dedzin\u0101\u0161anas l\u012bdzeklis un ener\u0123ijas pastiprin\u0101t\u0101js, \u0161\u012bs priek\u0161roc\u012bbas bie\u017ei vien ir saist\u012btas ar vair\u0101ku citu uztura bag\u0101tin\u0101t\u0101ju vienlaic\u012bgu lieto\u0161anu.<\/p><p>Tie\u0161saistes p\u0101rdev\u0113ji iesaka s\u0101kt terapiju ar 25 mcg dien\u0101, ned\u0113\u013cas laik\u0101 palielinot to par 5-10 mcg, bet aug\u0161\u0113j\u0101 robe\u017ea ir aptuveni 100 mcg dien\u0101. Person\u012bgie apraksti liecina, ka svara zaud\u0113\u0161anas termi\u0146i var sv\u0101rst\u012bties no 6 l\u012bdz 12 ned\u0113\u013c\u0101m, bet lietot\u0101jiem vajadz\u0113tu l\u0113n\u0101m samazin\u0101t lieto\u0161anu, lai atjaunotu vairogdziedzera funkciju.<\/p><p>Pirms vairogdziedzera hormonu lieto\u0161anas \u0101rpusre\u0123istr\u0113tiem m\u0113r\u0137iem, piem\u0113ram, svara zudumam, dro\u0161\u012bbas apsv\u0113rumu d\u0113\u013c ir ieteicams konsult\u0113ties ar \u0101rstu.<\/p><h3>Paz\u012bmes un simptomi<\/h3><p>P\u0101rm\u0113r\u012bgs vairogdziedzera hormonu l\u012bmenis var izrais\u012bt da\u017e\u0101das blakuspar\u0101d\u012bbas, tostarp:<\/p><ul>\n<li>Galvass\u0101pes<\/li>\n<li>Garast\u0101vok\u013ca sv\u0101rst\u012bbas: irritabilpums, trauksme<\/li>\n<li>Hiperhidroze<\/li>\n<li>Sirds aritmijas<\/li>\n<li>Palpit\u0101cija<\/li>\n<li>Diskomforts kr\u016bt\u012bs<\/li>\n<li>Caureja<\/li>\n<li>Menstru\u0101ciju p\u0101rk\u0101pumi<\/li>\n<li>Sirds mazsp\u0113jas pasliktin\u0101\u0161an\u0101s<\/li>\n<li>\u0160oks<\/li>\n<\/ul><p>Smagas p\u0101rdoz\u0113\u0161anas var izrais\u012bt simptomus, kas l\u012bdzin\u0101s vairogdziedzera v\u0113trai, un hroniskas p\u0101rdoz\u0113\u0161anas var izpausties k\u0101 hipertireo\u012bdas simptomi.<\/p><h3>Kontrindik\u0101cijas<\/h3><p>Vairogdziedzera hormonu lieto\u0161ana ir kontrindic\u0113ta person\u0101m ar ne\u0101rst\u0113tu virsnieru garozas nepietiekam\u012bbu, tireotoksikozi vai zin\u0101mu paaugstin\u0101tu jut\u012bbu. Aler\u0123iskas reakcijas pret liotiron\u012bnu tiek uzskat\u012btas par ret\u0101m, bet tom\u0113r iesp\u0113jam\u0101m.<\/p><h3>Paz\u012bmes un simptomi<\/h3><p>Vairogdziedzera hormoni tiek mekl\u0113ti svara zudumam, tom\u0113r, kombin\u0113jot tos ar citiem uztura bag\u0101tin\u0101t\u0101jiem, norm\u0101l\u0101s terapeitisk\u0101s dev\u0101s bie\u017ei var izrais\u012bt neefektivit\u0101ti. Tom\u0113r iev\u0113rojamas devas var izrais\u012bt b\u012bstamus rezult\u0101tus, \u012bpa\u0161i, ja t\u0101s lieto kop\u0101 ar t\u0101diem l\u012bdzek\u013ciem k\u0101 efedr\u012bns vai aug\u0161anas hormoni.<\/p><p>Piesardz\u012bba ir pamatota, ja ir da\u017eas saslim\u0161anas, jo \u0161ie hormoni var saasin\u0101t virsnieru mazsp\u0113ju un ietekm\u0113t diab\u0113ta p\u0101rvald\u012bbu. Tie var ar\u012b paaugstin\u0101t jut\u012bbu pret peror\u0101lajiem antikoagulantiem, palielinot asi\u0146o\u0161anas risku.<\/p><p>Apgalvojumiem par vairogdziedzera hormonu noz\u012bmi neaugl\u012bbas \u0101rst\u0113\u0161an\u0101 tr\u016bkst zin\u0101tniska apstiprin\u0101juma.<\/p><p>Vairogdziedzera hormoni var rad\u012bt b\u016btiskas blakuspar\u0101d\u012bbas. Person\u0101m ar sirds probl\u0113m\u0101m pirms terapijas uzs\u0101k\u0161anas, s\u0101kot tikai ar minim\u0101l\u0101m dev\u0101m, j\u0101v\u0113r\u0161as pie \u0101rsta.<\/p><h3>L\u012bme\u0146i<\/h3><p>Vairogdziedzera hormonu l\u012bmenis ir viegli kontrol\u0113jams. Sporta organiz\u0101cijas, tostarp SOK un WADA, regul\u0101ri p\u0101rbauda sportistu vairogdziedzera hormonu l\u012bmeni, izmantojot \u013coti jut\u012bgus radioim\u016bnu testus, kas sp\u0113j noteikt minim\u0101lus daudzumus ur\u012bn\u0101.<\/p><h3>Z\u0101\u013cu mijiedarb\u012bba<\/h3><p>Liotiron\u012bns var mijiedarboties ar daudziem medikamentiem:<\/p><ul>\n<li>Peror\u0101lie antikoagulanti<\/li>\n<li>Insul\u012bns vai peror\u0101lie hipoglikemiz\u0113jo\u0161ie l\u012bdzek\u013ci<\/li>\n<li>Holestiram\u012bns<\/li>\n<li>Estrog\u0113ni, tostarp peror\u0101lie kontracepcijas l\u012bdzek\u013ci<\/li>\n<li>Tricikliskie antidepresanti<\/li>\n<li>Digitalis<\/li>\n<\/ul><p>\u0100rstiem j\u0101nodro\u0161ina, lai vairogdziedzera hormonu devas joproj\u0101m b\u016btu atbilsto\u0161as. B\u016btiska ir regul\u0101ra \u0161\u0101du terapiju sa\u0146emo\u0161o pacientu uzraudz\u012bba.<\/p><h3>P\u0101rdoz\u0113\u0161anas \u0101rst\u0113\u0161ana<\/h3><p>P\u0101rdoz\u0113\u0161anas gad\u012bjum\u0101 pacienti nekav\u0113joties j\u0101hospitaliz\u0113. \u013boti svar\u012bga ir hormona lieto\u0161anas p\u0101rtrauk\u0161ana un r\u016bp\u012bga nov\u0113ro\u0161ana, bie\u017ei vien atvese\u013co\u0161anai nepiecie\u0161ams 4-8 ned\u0113\u013cu p\u0101rtraukums. Specifiska pretl\u012bdzek\u013ca nav; t\u0101 viet\u0101 galven\u0101 ir atbalsto\u0161a apr\u016bpe. Vem\u0161anas izrais\u012b\u0161ana ir kontrindic\u0113ta aspir\u0101cijas riska d\u0113\u013c. Komatozos gad\u012bjumos var b\u016bt nepiecie\u0161ama \u012bslaic\u012bga meh\u0101niska ventil\u0101cija. Parasti pietiek ar t\u0101diem atbalsta pas\u0101kumiem k\u0101 \u0161\u0137idruma reanim\u0101cija un nov\u0113ro\u0161ana, iesp\u0113jams, ievadot beta blokatorus, lai mazin\u0101tu simp\u0101tisk\u0101s reakcijas.<\/p><h3>Doz\u0113\u0161ana<\/h3><p>Liotiron\u012bnu parasti ievada tab table\u0161u veid\u0101, ko lieto katru dienu. Deva ir atkar\u012bga no hipotireozes smaguma pak\u0101pes, s\u0101kot no zem\u0101k\u0101s iesp\u0113jam\u0101s robe\u017ev\u0113rt\u012bbas, jo t\u0101 iedarb\u012bba s\u0101kas \u0101tri. S\u0101kotn\u0113j\u0101 Cytomel tablet deva ir 5 mcg dien\u0101, palielinot ne vair\u0101k k\u0101 5 mcg dien\u0101 ik p\u0113c 2-3 ned\u0113\u013c\u0101m. \u013boti svar\u012bgi ir izvair\u012bties no p\u0113k\u0161\u0146as devas palielin\u0101\u0161anas, \u012bpa\u0161i pacientiem ar sirdsdarb\u012bbas trauc\u0113jumiem. Liel\u0101kajai da\u013cai nepiecie\u0161amas devas no 50-75 mcg dien\u0101. Turkl\u0101t ir pieejama ar\u012b intravenoza liotiron\u012bna forma, ko da\u017ek\u0101rt izmanto mixed\u0113mas komas gad\u012bjum\u0101 - kritiska hipotireo\u012bdisma komplik\u0101cija, kas galvenok\u0101rt skar gados vec\u0101kas sievietes.<\/p><p>Liotiron\u012bna tab tabletes ir pieejamas 5, 25 un 50 mcg dev\u0101s. ASV L-tiron\u012bnam oblig\u0101ti vajadz\u012bga \u0101rsta recepte.<\/p><hr><h2>T4 - n\u0101trija liotiron\u012bns<\/h2><p>\u0160is sint\u0113tiskais vairogdziedzera hormons, ko parasti d\u0113v\u0113 par levotiroks\u012bnu, galvenok\u0101rt ir paredz\u0113ts hipotireozei un kalpo k\u0101 sint\u0113tiska alternat\u012bva vairogdziedzera hormoniem T4. T4 labv\u0113l\u012bgi ietekm\u0113 centr\u0101lo nervu sist\u0113mu, veicina tauku metabolismu un veicina visp\u0101r\u0113jo labsaj\u016btu.<\/p><h3>Doz\u0113\u0161ana<\/h3><p>100 - 300 mcg katru dienu<\/p><h3>Ietekme<\/h3><p>Sportisti, kas izmanto T4, var uzlabot savu fizisko veiktsp\u0113ju un efekt\u012bvi zaud\u0113t svaru, neizj\u016btot izsalkumu.<\/p><h3>Blakuspar\u0101d\u012bbas<\/h3><p>Bie\u017ei sastopam\u0101s blakuspar\u0101d\u012bbas, kas saist\u012btas ar T4, ir bezmiegs, tr\u012bce, trauksme, neregul\u0101ra sirdsdarb\u012bba un dabisk\u0101 vairogdziedzera hormonu ra\u017eo\u0161anas nom\u0101kums.<\/p><h3>Aizsardz\u012bba<\/h3><p>Lai mazin\u0101tu blakuspar\u0101d\u012bbas, apsveriet iesp\u0113ju sav\u0101 re\u017e\u012bm\u0101 iek\u013caut beta blokatorus un ketotif\u0113nu. Lietojiet T4 galvenok\u0101rt dienas s\u0101kum\u0101, lai samazin\u0101tu bezmiega risku.<\/p><h3>Krau\u0161anas<\/h3><p>Piesardz\u012bgi j\u0101r\u012bkojas, kombin\u0113jot T4 ar cit\u0101m z\u0101l\u0113m, kas ietekm\u0113 asinsspiedienu un sirds ritmu.<\/p>","protected":false},"excerpt":{"rendered":"<p><strong>Pharma Lab T3+T4 is a powerful blend of two essential thyroid hormones designed to enhance metabolic performance and support effective weight loss. Each tablet contains 30 mcg of T3 (liothyronine) and 120 mcg of T4 (levothyroxine), facilitating energy production and metabolism while offering a reliable option for athletes and individuals managing hypothyroidism.<\/strong><\/p>","protected":false},"featured_media":826938,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[399,398],"product_tag":[514,490,491,498,541,542],"class_list":{"0":"post-10329","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-t3-liothyronine","7":"product_cat-t4-levothyroxine","8":"product_tag-fat-loss","9":"product_tag-for-men","10":"product_tag-for-women","11":"product_tag-oral","12":"product_tag-t3-liothyronine","13":"product_tag-t4-levothyroxine","14":"pa_brand-pharma-lab","16":"first","17":"outofstock","18":"sale","19":"shipping-taxable","20":"purchasable","21":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product\/10329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/comments?post=10329"}],"version-history":[{"count":12,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product\/10329\/revisions"}],"predecessor-version":[{"id":834721,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product\/10329\/revisions\/834721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/media\/826938"}],"wp:attachment":[{"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/media?parent=10329"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product_brand?post=10329"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product_cat?post=10329"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product_tag?post=10329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}